<?xml version="1.0" encoding="UTF-8"?>
<mods xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" version="3.1" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-1.xsd">
  <titleInfo>
    <title>Smoking cessation and related indications: Developing nicotine replacement therapy drug products guidance for industry</title>
  </titleInfo>
  <name type="corporate">
    <namePart>U.S. Department of Health and Human Services</namePart>
    <role>
      <roleTerm authority="marcrelator" type="text">creator</roleTerm>
    </role>
  </name>
  <typeOfResource>text</typeOfResource>
  <genre authority="">Documental</genre>
  <originInfo>
    <place>
      <placeTerm type="code" authority="marccountry">sp</placeTerm>
    </place>
    <place>
      <placeTerm type="text">Beltsville</placeTerm>
    </place>
    <publisher>Center for Drug Evaluation and Research</publisher>
    <dateIssued>2023</dateIssued>
    <issuance>monographic</issuance>
  </originInfo>
  <language>
    <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
  </language>
  <language>
    <languageTerm authority="iso639-2b" type="code">eng</languageTerm>
  </language>
  <physicalDescription>
    <form authority="marcform">print</form>
    <extent>20 p.</extent>
  </physicalDescription>
  <abstract>El objetivo de esta guía es ayudar a los patrocinadores en el desarrollo clínico de fármacos de terapia de sustitución de nicotina, incluidos, entre otros, los destinados a ayudar a los fumadores a dejar de fumar cigarrillos.</abstract>
  <subject>
    <topic>Drogodependencias</topic>
  </subject>
  <subject>
    <topic>Tabaquismo</topic>
  </subject>
  <subject>
    <topic>Desintoxicación</topic>
  </subject>
  <subject>
    <topic>Industria</topic>
  </subject>
  <subject>
    <topic>Fármacos</topic>
  </subject>
  <subject>
    <topic>Venta</topic>
  </subject>
  <subject>
    <topic>Tratamiento médico</topic>
  </subject>
  <subject>
    <topic>Nicotina de sustitución</topic>
  </subject>
  <subject>
    <topic>Programas de mantenimiento</topic>
  </subject>
  <subject>
    <topic>Reducción de riesgo</topic>
  </subject>
  <subject>
    <topic>Recaída</topic>
  </subject>
  <subject>
    <topic>Criterios</topic>
  </subject>
  <subject>
    <topic>Seguridad</topic>
  </subject>
  <subject>
    <topic>Administración</topic>
  </subject>
  <subject>
    <topic>Recomendaciones</topic>
  </subject>
  <subject>
    <geographic>EE.UU</geographic>
  </subject>
  <subject>
    <topic>Adicciones</topic>
  </subject>
  <identifier type="uri">https://www.fda.gov/media/167599/download</identifier>
  <identifier type="uri">https://www.siis.net/documentos/Path/597005.pdf</identifier>
  <location>
    <url>https://www.fda.gov/media/167599/download</url>
  </location>
  <location>
    <url>https://www.siis.net/documentos/Path/597005.pdf</url>
  </location>
  <recordInfo>
    <recordContentSource authority="marcorg">SIIS</recordContentSource>
    <recordCreationDate encoding="marc">241017</recordCreationDate>
    <recordChangeDate encoding="iso8601">20250218135152.0</recordChangeDate>
    <languageOfCataloging>
      <languageTerm authority="iso639-2b" type="code">spa</languageTerm>
    </languageOfCataloging>
  </recordInfo>
</mods>
